HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: clinchem.2008.112243v1 54/12/2042    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Eichinger, S. Articles by Kyrle, P. A. Search for Related Content PubMed PubMed Citation Articles by Eichinger, S. Articles by Kyrle, P. A.

Prediction of Recurrent Venous Thromboembolism by Endogenous Thrombin Potential and D-Dimer

¹ Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

^aAddress correspondence to this author at: Department of Internal Medicine I, Medical University of Vienna, Waehringer Guertel 18–20, 1090 Wien, Austria. Fax +43-40400-4030; e-mail sabine.eichinger{at}meduniwien.ac.at.

Background: Increased thrombin generation is associated with an increased risk of recurrent venous thromboembolism. We investigated the relation between endogenous thrombin potential (ETP) and risk of recurrent venous thromboembolism and evaluated whether prediction of recurrence can be improved by a combined analysis of ETP and D-dimer.

Methods: We followed 861 patients with first spontaneous venous thromboembolism and determined ETP and D-dimer after discontinuation of anticoagulation. Patients with natural inhibitor deficiency, lupus anticoagulant, or cancer were excluded. The study endpoint was symptomatic recurrent venous thromboembolism.

Results: One hundred thirty patients (15.1%) had recurrence. High ETP (100%) conferred a 1.6-fold increased risk of recurrence (95% CI 1.1–2.3) after adjustment for age, sex, factor V Leiden, factor II G20210A, and duration of anticoagulation. After adjustment for D-dimer, risk of recurrence remained significantly higher among patients with high ETP [hazard ratio 1.6 (95% CI 1.01–2.4)]. After adjustment for ETP, high D-dimer (0.5 mg/L) conferred a 1.8-fold (95% CI 1.1–2.8) increased risk of recurrence. Compared with patients with low ETP and low D-dimer, risk of recurrence was 2.8-fold (95% CI 1.5–5.3) higher among patients with both high ETP and high D-dimer after adjustment for potential confounders.

Conclusions: ETP and D-dimer are independent predictors of recurrent venous thromboembolism. Assessing risk of recurrence can be optimized by combining these indicators of thrombin generation.

The following articles in journals at HighWire Press have cited this article:

				I. Pabinger and C. Ay Biomarkers and Venous Thromboembolism Arterioscler. Thromb. Vasc. Biol., March 1, 2009; 29(3): 332 - 336. [Abstract] [Full Text] [PDF]

				T. K. Brock, N. L. Gentile, R. F. Louie, N. K. Tran, T. Kitano, and G. J. Kost Assessing Thrombin Generation at the Point of Care Clin. Chem., March 1, 2009; 55(3): 398 - 399. [Full Text] [PDF]